Tauopathy in AD can be initiated by Aβ42‐mediated activation of mGluR5, and both pathological tau and Aβ42 oligomers act together to impair neuronal circuits and disrupt synaptic transmission.50 The gene discussed is MAPT; the disease is tauopathy.